Investing Profile

Daniel van den Bergh(42)

VC
Healthcare technology investor at Kaiser Permanente Ventures
kpventures.comSan Francisco, California
Photo of Daniel van den Bergh, Partner at Kaiser Permanente Ventures
Your Intro Paths to Daniel van den Bergh

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Daniel van den Bergh's investing connections

Picture
Picture
Picture

6 Investors

Connected to Gyan Kapur (Surface Ventures), Scott Barclay (Insight Partners), Shruti Gandhi (Array Ventures), and 3 other investors on Signal.

Networks Daniel is a member of
Cornell University Network
128 CONNECTIONS
The Wharton School Network
108 CONNECTIONS

Find Daniel van den Bergh on

cb
Current Investing Position
Kaiser Permanente Ventures Partner
Investment Range
$5.0M - $15.0M
Sweet Spot
$7.0M
Investments On Record
10
Current Fund Size
$141M

Daniel van den Bergh is on these Sector & Stage Rankings

Daniel van den Bergh's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
HealthJoy
Series DOct 2022$12M
Series DOct 2022$12M
$130M
Co-investors: Stuart Larkins (Chicago Ventures), Martin Alexander Gershon (Endeavor Venture Funds), Aneesha Mehta (Valspring Capital), Saurabh Bhansali (Health Velocity Capital), Jack Boren
Ordr
Series BMar 2020$34M
$120M
Co-investors: Dharmesh Thakker (Battery Ventures), Alex Doll (Ten Eleven Ventures), René Bonvanie (Cyberstarts VC), Daniel Warmenhoven, Pankaj Patel
Nuvolo
Series BJul 2019$12M
$54M
Co-investors: Richard Wells (Insight Partners), Henry Frankievich (Insight Partners), Noah Lewis (GE Ventures)
NextHealth Technologies
Series BMar 2019$20M
$20M
Protenus
Series AJul 2017$7M
$66M
Co-investors: Jon Lim (F-Prime Capital Partners), Patrick Meenan (Arthur Ventures)
QuantiaMD
Series EAug 2013$12M
$12M
Sotera Wireless
Series D1May 2013$15M
$94M
Co-investors: Bobby Kandaswamy (National Grid Partners)
NuPathe
PIPEOct 2012$28M
$28M

most interested in

Enterprise healthcare IT, digital health, tech-enabled healthcare services, medical technology

not interested in

new molecule risk

Daniel van den Bergh's Experience

Senior Investment Director Kaiser Permanente Ventures2024 - Present
Senior Investment Director Endeavour Vision2022 - 2024
Investment Director Kaiser Permanente Ventures2017 - 2022
Director, Strategy & Operations Lumiata2015 - 2017
Summer Associate Longitude Capital2014 - 2014
Associate, Venture Capital Safeguard Scientifics2011 - 2013
Associate, Healthcare M&A EC Mergers & Acquisitions2009 - 2011
Analyst, Investment Banking Citigroup Global Markets2007 - 2009
Summer Analyst Lux Capital2006 - 2006

Daniel van den Bergh's Education

The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering